Midday movers: Allergan, Freshpet, Transocean & more

NYSE New York Stock Exchange
Scott Mlyn | CNBC

Take a look at some of Friday's midday movers:

Abercrombie & Fitch - The clothing retailer declined after reporting sales fell more than expected in September and October.

General Mills - The cereal maker dropped after cutting its full-year sales and profit growth outlook.

Intercept Pharmaceuticals - The drug manufacturer tanked after reporting a larger-than-expected quarterly loss.

JPMorgan Chase - The bank edged up after saying it would cut 3,000 more jobs than previously anticipated in its retail banking unit.

Avanir Pharmaceuticals - The drug developer declined after saying the Food and Drug Administration had raised concerns about its migraine treatment.

Allergan - The Botox maker fell after its biggest shareholder urged the company in a letter to give Valeant Pharmaceuticals a shot at buying it.

Agios Pharmaceuticals - The biopharmaceutical company slid after reporting weaker-than-expected third-quarter earnings.

Transocean - The offshore driller slipped after saying it would incur more than $2.7 billion in charges due to reduced demand for its rigs.

DaVita Healthcare Partners - The supplier of kidney dialysis fell after posting weaker-than-expected third-quarter results.

Medivation - The developer of a cancer drug rose after reporting a better-than-expected third-quarter profit.

Freshpet - The maker of healthy food for dogs and cats soared in its trading debut.

Fastenal -The maker of industrial fasteners dropped after saying its chief executive was stepping down.

(See CNBC's Market Insider Blog)

Questions? Comments? Email us at marketinsider@cnbc.com